Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses

17 augustus 2026 bijgewerkt door: Ang Wei How Darryl, National University of Singapore

Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses: A Mixed Methods Study

The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations

This study aims to address the following research questions:

  • Does the PEACE program improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations?
  • What are the participants' experiences of participating in the PEACE program?

Researchers will compare participants who receive the PEACE program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.

Participants will:

  • Complete online questionnaires measuring attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
  • Participate in a facilitator-led group discussion session about experiences of patients' deaths, coping with patients' death and dying, communications with patients and/or family members about death and dying, and discussing advance care planning with patients and/or family members (intervention group only).
  • Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
  • Complete follow-up surveys, including a 3-month follow-up assessing whether participants have engage with any patients and/or their family members in advance care planning conversations.

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Interventie / Behandeling

Studietype

Ingrijpend

Inschrijving (Geschat)

150

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

  • Singapore
      • Singapore, Singapore
        • National University of Singapore
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  • Registered nurses within the first five years of practice
  • Between the ages of 21 to 65 years
  • Currently working in a healthcare setting in SIngapore

Exclusion Criteria:

  • Participated in a similar death conversation program
  • Received training in Advance Care Planning or Serious Illness Conversations
  • Any self-reported history of mental health disorders (e.g., depression), or neurological disorders (e.g., brain tumors)

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Intervention Group - on site group discussions + online learning session

Participants in this arm will receive the two-session PEACE Program.

Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering:

  1. Experiences of death and dying
  2. Coping with death and dying.
  3. Communication about death and dying
  4. Discussing Advance Care Planning (ACP).

Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums.
Gedragsmatig: Online ACP-opleiding
Een online asynchrone leersessie met korte video's over ACP met discussieforums.
Gedragsmatig: Death Conversation
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Experiences of patients' deaths; 2) Coping with patients' death and dying; 3) Communication with patients and/or family members about death and dying; 4) Discussing advance care planning with patients and/or family members
Actieve vergelijker: Control Group - Only online learning session
Participants in this arm will only receive the online ACP education component, identical to Session 2 of the PEACE programme. No facilitator-led group discussions are provided.
Gedragsmatig: Online ACP-opleiding
Een online asynchrone leersessie met korte video's over ACP met discussieforums.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Frommelt Attitude Toward Care of the Dying Scale
Tijdsspanne: Baseline
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
Baseline
Frommelt Attitude Toward Care of the Dying Scale
Tijdsspanne: Post-test (Immediately at end of 2-weeks intervention)
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
Post-test (Immediately at end of 2-weeks intervention)
Frommelt Attitude Toward Care of the Dying Scale
Tijdsspanne: 3 months follow-up
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
3 months follow-up

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Palliative care self-efficacy scale
Tijdsspanne: Baseline
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
Baseline
Palliative care self-efficacy scale
Tijdsspanne: Post-test (Immediately at end of 2-weeks intervention)
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
Post-test (Immediately at end of 2-weeks intervention)
Palliative care self-efficacy scale
Tijdsspanne: 3 months follow-up
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
3 months follow-up
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Tijdsspanne: Baseline
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
Baseline
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Tijdsspanne: Post-test (Immediately at end of 2-weeks intervention)
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
Post-test (Immediately at end of 2-weeks intervention)
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Tijdsspanne: 3 months follow-up
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
3 months follow-up
End-of-life planning conversations
Tijdsspanne: 3 months follow-up
Self-reported number of conversations held with patients regarding Advance Care Planning
3 months follow-up

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

National University of Singapore

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 september 2026

Primaire voltooiing (Geschat)

31 december 2027

Studie voltooiing (Geschat)

31 december 2027

Studieregistratiedata

Eerst ingediend

11 augustus 2026

Eerst ingediend dat voldeed aan de QC-criteria

17 augustus 2026

Eerst geplaatst (Werkelijk)

19 augustus 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

19 augustus 2026

Laatste update ingediend die voldeed aan QC-criteria

17 augustus 2026

Laatst geverifieerd

1 augustus 2026

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • NUS-DERC-001647
  • A-0010425-00-00 (Ander subsidie-/financieringsnummer: National University of Singapore)

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren